新型冠状病毒

Germany clashes with other EU states on pharma regulation overhaul
德国与欧盟其他国家就制药业监管改革发生冲突

Berlin warns shortening time before generic drugs are allowed to market will stifle industry investment
柏林方面警告称,缩短仿制药获准上市前的时间将扼杀制药行业投资。

Germany and several smaller member states have mounted opposing last-ditch lobbying efforts over EU pharmaceutical legislation to be published next week, with Berlin warning that it would damage investment by the drug industry.   

德国和几个较小的欧盟成员国就欧盟将于下周公布的药品立法立场冲突,正在进行各自最后的游说。柏林方面警告称,此次改革将损害制药业的投资。

您已阅读6%(296字),剩余94%(4573字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×